Amarin Gets Wider Approval for Heart Drug, Likely Boosting Sales

(Bloomberg) -- Amarin Corp. won an expanded U.S. approval for its cardiovascular drug Vascepa, opening the market for the fish-oil based therapy to potentially millions more patients and giving the...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.